While EGFR mutations are more commonly observed in patients with these clinical characteristics (i.e., Asian ethnicity, adenocarcinoma histology, etc.), they can occur in patients who do not fit these characteristics as well. This evidence concerns the gene EGFR and adenocarcinoma.